🇺🇸 FDA
Patent

US 8883211

Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds

granted A61KA61K9/1272

Quick answer

US patent 8883211 (Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds) held by Serina Therapeutics, Inc. expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Serina Therapeutics, Inc.
Grant date
Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K9/1272